RBC Capital analyst Wayne Lam downgrades Equinox Gold (AMEX:EQX) from Sector Perform to Underperform.
Vanda Pharmaceuticals Adopts 1-Year Term Limited Duration Stockholder Rights Plan To Protect Stockholder Interests And Maximize Value For All Stockholders, Effective Immediately
Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect
